1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neurovascular Devices/Interventional Neurology Revenue
1.4 Market Analysis by Type
1.4.1 Global Neurovascular Devices/Interventional Neurology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Aneurysm Coiling & Embolization Devices
1.4.3 Cerebral Balloon Angioplasty & Stenting Systems
1.4.4 Support Devices
1.4.5 Neurothrombectomy Devices
1.5 Market by Application
1.5.1 Global Neurovascular Devices/Interventional Neurology Market Share by Application: 2021-2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Units
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Neurovascular Devices/Interventional Neurology Market
1.8.1 Global Neurovascular Devices/Interventional Neurology Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Neurovascular Devices/Interventional Neurology Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Neurovascular Devices/Interventional Neurology Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Neurovascular Devices/Interventional Neurology Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Neurovascular Devices/Interventional Neurology Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Neurovascular Devices/Interventional Neurology Sales Volume Market Share by Region (2015-2020)
3.2 Global Neurovascular Devices/Interventional Neurology Sales Revenue Market Share by Region (2015-2020)
3.3 North America Neurovascular Devices/Interventional Neurology Sales Volume
3.3.1 North America Neurovascular Devices/Interventional Neurology Sales Volume Growth Rate (2015-2020)
3.3.2 North America Neurovascular Devices/Interventional Neurology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Neurovascular Devices/Interventional Neurology Sales Volume
3.4.1 East Asia Neurovascular Devices/Interventional Neurology Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Neurovascular Devices/Interventional Neurology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Neurovascular Devices/Interventional Neurology Sales Volume (2015-2020)
3.5.1 Europe Neurovascular Devices/Interventional Neurology Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Neurovascular Devices/Interventional Neurology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Neurovascular Devices/Interventional Neurology Sales Volume (2015-2020)
3.6.1 South Asia Neurovascular Devices/Interventional Neurology Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Neurovascular Devices/Interventional Neurology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Neurovascular Devices/Interventional Neurology Sales Volume (2015-2020)
3.7.1 Southeast Asia Neurovascular Devices/Interventional Neurology Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Neurovascular Devices/Interventional Neurology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Neurovascular Devices/Interventional Neurology Sales Volume (2015-2020)
3.8.1 Middle East Neurovascular Devices/Interventional Neurology Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Neurovascular Devices/Interventional Neurology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Neurovascular Devices/Interventional Neurology Sales Volume (2015-2020)
3.9.1 Africa Neurovascular Devices/Interventional Neurology Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Neurovascular Devices/Interventional Neurology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Neurovascular Devices/Interventional Neurology Sales Volume (2015-2020)
3.10.1 Oceania Neurovascular Devices/Interventional Neurology Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Neurovascular Devices/Interventional Neurology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Neurovascular Devices/Interventional Neurology Sales Volume (2015-2020)
3.11.1 South America Neurovascular Devices/Interventional Neurology Sales Volume Growth Rate (2015-2020)
3.11.2 South America Neurovascular Devices/Interventional Neurology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Neurovascular Devices/Interventional Neurology Sales Volume (2015-2020)
3.12.1 Rest of the World Neurovascular Devices/Interventional Neurology Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Neurovascular Devices/Interventional Neurology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Neurovascular Devices/Interventional Neurology Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Neurovascular Devices/Interventional Neurology Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Neurovascular Devices/Interventional Neurology Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Neurovascular Devices/Interventional Neurology Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Neurovascular Devices/Interventional Neurology Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Neurovascular Devices/Interventional Neurology Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Neurovascular Devices/Interventional Neurology Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Neurovascular Devices/Interventional Neurology Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Neurovascular Devices/Interventional Neurology Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Neurovascular Devices/Interventional Neurology Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Neurovascular Devices/Interventional Neurology Sales Volume Market Share by Type (2015-2020)
14.2 Global Neurovascular Devices/Interventional Neurology Sales Revenue Market Share by Type (2015-2020)
14.3 Global Neurovascular Devices/Interventional Neurology Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Neurovascular Devices/Interventional Neurology Consumption Volume by Application (2015-2020)
15.2 Global Neurovascular Devices/Interventional Neurology Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Neurovascular Devices/Interventional Neurology Business
16.1 Stryker Corporation
16.1.1 Stryker Corporation Company Profile
16.1.2 Stryker Corporation Neurovascular Devices/Interventional Neurology Product Specification
16.1.3 Stryker Corporation Neurovascular Devices/Interventional Neurology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 W. L. Gore & Associates
16.2.1 W. L. Gore & Associates Company Profile
16.2.2 W. L. Gore & Associates Neurovascular Devices/Interventional Neurology Product Specification
16.2.3 W. L. Gore & Associates Neurovascular Devices/Interventional Neurology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Terumo
16.3.1 Terumo Company Profile
16.3.2 Terumo Neurovascular Devices/Interventional Neurology Product Specification
16.3.3 Terumo Neurovascular Devices/Interventional Neurology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Johnson & Johnson
16.4.1 Johnson & Johnson Company Profile
16.4.2 Johnson & Johnson Neurovascular Devices/Interventional Neurology Product Specification
16.4.3 Johnson & Johnson Neurovascular Devices/Interventional Neurology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Abbott Vascular
16.5.1 Abbott Vascular Company Profile
16.5.2 Abbott Vascular Neurovascular Devices/Interventional Neurology Product Specification
16.5.3 Abbott Vascular Neurovascular Devices/Interventional Neurology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Medtronic
16.6.1 Medtronic Company Profile
16.6.2 Medtronic Neurovascular Devices/Interventional Neurology Product Specification
16.6.3 Medtronic Neurovascular Devices/Interventional Neurology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Microport Scientific Corporation
16.7.1 Microport Scientific Corporation Company Profile
16.7.2 Microport Scientific Corporation Neurovascular Devices/Interventional Neurology Product Specification
16.7.3 Microport Scientific Corporation Neurovascular Devices/Interventional Neurology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Penumbra
16.8.1 Penumbra Company Profile
16.8.2 Penumbra Neurovascular Devices/Interventional Neurology Product Specification
16.8.3 Penumbra Neurovascular Devices/Interventional Neurology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Neurovascular Devices/Interventional Neurology Manufacturing Cost Analysis
17.1 Neurovascular Devices/Interventional Neurology Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Neurovascular Devices/Interventional Neurology
17.4 Neurovascular Devices/Interventional Neurology Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Neurovascular Devices/Interventional Neurology Distributors List
18.3 Neurovascular Devices/Interventional Neurology Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Neurovascular Devices/Interventional Neurology (2021-2026)
20.2 Global Forecasted Revenue of Neurovascular Devices/Interventional Neurology (2021-2026)
20.3 Global Forecasted Price of Neurovascular Devices/Interventional Neurology (2015-2026)
20.4 Global Forecasted Production of Neurovascular Devices/Interventional Neurology by Region (2021-2026)
20.4.1 North America Neurovascular Devices/Interventional Neurology Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Neurovascular Devices/Interventional Neurology Production, Revenue Forecast (2021-2026)
20.4.3 Europe Neurovascular Devices/Interventional Neurology Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Neurovascular Devices/Interventional Neurology Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Neurovascular Devices/Interventional Neurology Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Neurovascular Devices/Interventional Neurology Production, Revenue Forecast (2021-2026)
20.4.7 Africa Neurovascular Devices/Interventional Neurology Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Neurovascular Devices/Interventional Neurology Production, Revenue Forecast (2021-2026)
20.4.9 South America Neurovascular Devices/Interventional Neurology Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Neurovascular Devices/Interventional Neurology Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Neurovascular Devices/Interventional Neurology by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Neurovascular Devices/Interventional Neurology by Country
21.2 East Asia Market Forecasted Consumption of Neurovascular Devices/Interventional Neurology by Country
21.3 Europe Market Forecasted Consumption of Neurovascular Devices/Interventional Neurology by Countriy
21.4 South Asia Forecasted Consumption of Neurovascular Devices/Interventional Neurology by Country
21.5 Southeast Asia Forecasted Consumption of Neurovascular Devices/Interventional Neurology by Country
21.6 Middle East Forecasted Consumption of Neurovascular Devices/Interventional Neurology by Country
21.7 Africa Forecasted Consumption of Neurovascular Devices/Interventional Neurology by Country
21.8 Oceania Forecasted Consumption of Neurovascular Devices/Interventional Neurology by Country
21.9 South America Forecasted Consumption of Neurovascular Devices/Interventional Neurology by Country
21.10 Rest of the world Forecasted Consumption of Neurovascular Devices/Interventional Neurology by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer